Completed PHASE4 INTERVENTIONAL 2-arm NCT03769714

EXPAREL for Minimally Invasive Supracervical Hysterectomies

A Placebo-controlled, Double-blinded, Randomized Pilot Study of Bupivacaine Liposome Injectable Suspension (EXPAREL) for Minimally Invasive Supracervical Hysterectomies Postsurgical Analgesia

Sponsor: Maimonides Medical Center

Conditions Pain

Interventions Exparel Saline Solution for Injection

Updated 5 times since 2019 Last updated: Jan 8, 2024 Started: Oct 1, 2018 Primary completion: Jun 30, 2019 Completion: Jun 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pain, this trial is completed. The trial is conducted by Maimonides Medical Center and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Feb 2024 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — Feb 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2019 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maimonides Medical Center

Data source: Maimonides Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brooklyn, United States